Hemodialysis through the body blood drainage to the outside of the body, through a dialyzer consisting of countless hollow fibers, blood and electrolyte solution (dialysate) containing similar concentrations of the body inside and outside of a hollow fiber, through the diffusion, ultrafiltration, adsorption and convection principles of material **, ** body of the metabolic wastes, to maintain the electrolyte and acid-base balance. That hemodialysis concept stock what are they?
Hemodialysis Concept Stocks List
1, Baolite (300246), the company is mainly engaged in the research and development of medical monitors and related medical equipment, production and marketing **, is a professional ** medical monitoring equipment, is in a leading position in the country.
2, blue sail medical (002382), the production and processing of PVC gloves and other plastic products, granules, sales * products produced by the company; ** gloves, latex gloves, pulp molded products, a class of medical equipment products ** business (does not involve the management of state trade commodities; commodities involved in the management of quotas, licenses and special provisions, in accordance with the relevant provisions of the state **).
3, Huaren Pharmaceutical (300110), by the People's Liberation Army General Hospital and Qingdao Huaren Pharmaceutical *** with the formation of blood purification products R & D center was officially opened. Membrane dialysis products R & D center, the R & D center set peritoneal dialysis products R & D and related personnel training in one, will systematically carry out research on key technologies of peritoneal dialysis products, accelerate the localization of peritoneal dialysis products, break the monopoly of foreign enterprises on the market pattern.
4, Sihuan Biological (000518), Jiangsu Sihuan Biological Co., Ltd. is a biomedical technology and traditional medicine combined with the modernization of pharmaceutical production enterprises, the main hepatitis diagnostic reagents, injections, in vitro diagnostic reagents. The main products are recombinant human interleukin-2, recombinant human epidermal growth factor, recombinant human granulocyte colony-stimulating factor, recombinant human erythropoietin, hepatitis diagnostic reagents, in vitro diagnostic reagents, injections and so on. The company has an infusion workshop with an annual capacity of 20 million bottles (bags), an injection workshop with a capacity of 300 million, a solid preparation workshop with a capacity of 3 billion tablets (capsules), a Chinese medicine and wine workshop with a capacity of 5 million, and a raw material workshop with an annual capacity of 1,000 tons. The company also owns advanced equipments such as non-PVC soft pack infusion production line, FTIR spectrometer, water treatment system, capsule filling machine, etc. imported from abroad.
5, Dongcheng Pharmaceutical (002675), the company's heparin sodium API through the U.S. FDA on-site audit, the European Union EDQM CEP certification, Germany, Hamburg, GMP certification, to obtain the Japanese PMDA certificate and other ** audit; chondroitin sulfate to obtain the European Union EDQM CEP certification, Germany, Hamburg, GMP certification and the United States USP certificate. The company's API Heparin Sodium and Chondroitin Sulfate products are exported to more than 30 countries and regions around the world. As for the preparation business, as of the end of 2014, the company has 7 dosage forms***49 kinds of drug varieties and specifications, among which six varieties are included in the national basic drug catalog, namely, *Bromisol Hydrochloride Dispersible Tablets, Liuweidihuang Capsules, Compound Danshen Tablets, Chorionicotin for Injection, Urotropin for Injection, Hydrocortisone Sodium Succinate for Injection; and six varieties are included in the National Health Insurance Catalog, namely, Anti-fungus and Anti-itching Pellets, Xinshe Tablets, Anti-Cancer Ping Tablets, Compound/Danshen Tablets, Pain Relief.
6, Xinhua Medical (600587), licensed to operate: Class II disinfection and sterilization equipment and appliances (6857), three types of medical high-energy radiation equipment (6832), three types of medical nuclide equipment (6833), two or three types of medical X-ray equipment (6830), two or three types of operating rooms, emergency rooms, diagnostic and treatment room equipment and appliances (6854), two types of dental Equipment and appliances (6855), Class II medical ultrasound instruments and related equipment (6823), Class II ward care equipment and appliances (6856), Class II medical laser instrumentation and equipment (6824), Class II and Class III software (6850) production, sales * (valid until March 9, 2015); Class II and Class III medical device products (one-time use of sterile medical devices, hearing aids, Contact lenses and care solution, in vitro diagnostic reagents except) sales * (valid until July 9, 2013); license approved within the scope of disinfectants, disinfection equipment production and sales * (valid until June 21, 2015) General business items: pharmaceutical equipment, environmental protection equipment sales *; instrumentation and supporting software production; building construction, air purification engineering and interior decoration engineering design, construction, decoration, medical, pharmaceutical equipment installation and construction of building intelligence.
7, and good shares (300273), the company intends to invest 22 million yuan to acquire Zhuhai Hong _, to expand the field of blood purification. Zhuhai Hong _ was founded in 2001, the main products are HF400, hemodialyzer reuse device. Among them, Hong_HF400 products have a strong degree of focus, making the product in the field of blood purification advantages.